Drug and method of treating or preventing renal disease using drug
A drug for renal disease, the drug including a compound represented by the following Formula (I) as an active ingredient.
1. A method of treating renal disease in a subject having renal disease, the method comprising administering the drug comprising a compound represented by the following Formula (I) or a salt thereof as an active ingredient to the subject at an effective amount for treating renal disease, wherein the renal disease is acute renal disease caused by acute renal ischemia:
wherein * represents a bonding site.
2. The method according to claim 1 , wherein the effective amount is 0.01 to 30 mg/kg as a single effective dose for an adult.
3. The method according to claim 1 , wherein the drug is administered with other medical agent simultaneously or/and at different times.
4. The method according to claim 1 , wherein the drug is administered with an anticancer agent simultaneously or/and at different times.
5. The method according to claim 1 , wherein the drug is administered with cisplatin simultaneously or/and at different times.
6. The method according to claim 1 , wherein the compound is SMTP-7 or a salt thereof.
7. The method according to claim 1 , wherein the compound is SMTP-7.
8. A method of treating renal disease in a subject having renal disease, the method comprising administering the drug comprising a compound represented by the following Formula (I) or a salt thereof as an active ingredient to the subject at an effective amount for treating renal disease, wherein the renal disease is acute renal disease caused by cisplatin nephropathy
wherein * represents a bonding site.
9. The method according to claim 8 , wherein the effective amount is 0.01 to 30 mg/kg as a single effective dose for an adult.
10. The method according to claim 8 , wherein the drug is administered with other medical agent simultaneously or/and at different times.
11. The method according to claim 8 , wherein the drug is administered with an anticancer agent simultaneously or/and at different times.
12. The method according to claim 8 , wherein the drug is administered with cisplatin simultaneously or/and at different times.
13. The method according to claim 8 , wherein the compound represented by the Formula (I) or the salt thereof is SMTP-7.
14. A method of treating renal disease in a subject having renal disease, the method comprising administering the drug comprising a compound represented by the following Formula (I) or a salt thereof as an active ingredient to the subject at an effective amount for treating renal disease, wherein the renal disease is chronic renal disease caused by cisplatin nephropathy
wherein * represents a bonding site.
15. The method according to claim 14 , wherein the effective amount is 0.01 to 30 mg/kg as a single effective dose for an adult.
16. The method according to claim 14 , wherein the drug is administered with other medical agent simultaneously or/and at different times.
17. The method according to claim 14 , wherein the drug is administered with an anticancer agent simultaneously or/and at different times.
18. The method according to claim 14 , wherein the drug is administered with cisplatin simultaneously or/and at different times.
19. The method according to claim 14 , wherein the compound represented by the Formula (I) or the salt thereof is SMTP-7.